The Transcatheter Aortic Valve Replacement (TAVR) market is a segment of the Cardiovascular Devices industry. It is a minimally invasive procedure used to replace a diseased aortic valve with a prosthetic valve. The procedure is typically used in patients who are at high risk for open-heart surgery. The TAVR market has seen rapid growth in recent years due to its advantages over traditional open-heart surgery, such as shorter recovery times and lower risk of complications. The TAVR market is highly competitive, with a number of companies offering products and services. Major players in the market include Edwards Lifesciences, Medtronic, Boston Scientific, Abbott, and LivaNova. These companies offer a range of products, including prosthetic valves, delivery systems, and accessories. Additionally, many of these companies have developed partnerships with healthcare providers to expand their reach and increase their market share. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
